Home / News release
Feng Guosheng, chief of Beijing Municipal Administration of Hospitals announced further reforms to reduce the price of drugs sold in hospitals.
A key measure of the reforms, currently under way in many public hospitals in China, including in Beijing, is for public hospitals to stop selling drugs up to 15 percent above the price they pay from the pharmaceutical companies, a practice that has been adopted by public hospitals for many years as major means of income.
Since Beijing's 2012 reform at five hospitals, medical expenditures of patients staying in these hospitals have reduced nearly 10 percent.
"More reforms in the circulation of drugs, such as reforms in bidding and the process of purchasing drugs, are needed to cut the link between doctors and representatives of pharmaceutical companies to further bring down the prices of drugs sold in hospitals," said Feng.
Feng made the comment at an event to mark the first anniversary of the Beijing Tsinghua Changgung Hospital, which is affiliated to Tsinghua University. More than 600 health officials and experts from the Chinese mainland, Taiwan, and the United States attended the event.
